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It is not economically feasible to sequence all study subjects in a
large cohort. A cost-effective strategy is to sequence only the
subjects with the extreme values of a quantitative trait. In the
National Heart, Lung, and Blood Institute Exome Sequencing Pro-
ject, subjects with the highest or lowest values of bodymass index,
LDL, or blood pressure were selected for whole-exome sequencing.
Failure to account for such trait-dependent sampling can cause
severe inflation of type I error and substantial loss of power in
quantitative trait analysis, especially when combining results from
multiple studies with different selection criteria. We present valid
and efficient statistical methods for association analysis of sequenc-
ing data under trait-dependent sampling. We pay special attention
to gene-based analysis of rare variants. Ourmethods can be used to
perform quantitative trait analysis not only for the trait that is used
to select subjects for sequencing but for any other traits that are
measured. For a particular trait of interest, our approach properly
combines the association results from all studies with measure-
ments of that trait. This meta-analysis is substantially more power-
ful than the analysis of any single study. By contrast, meta-analysis
of standard linear regression results (ignoring trait-dependent
sampling) can be less powerful than the analysis of a single study.
The advantages of theproposedmethods are demonstrated through
simulation studies and the National Heart, Lung, and Blood In-
stitute Exome Sequencing Project data. Themethods are applicable
to other types of genetic association studies and nongenetic studies.
Recent technological advances have made it possible to se-quence genomic regions for association studies. At the present
time, it is prohibitively expensive to perform large-scale whole-
exome sequencing. In the near future, whole-exome sequencing
on thousands of subjects will be economically feasible, but not
whole-genome sequencing. If a quantitative trait is of primary
interest in a large cohort study, a cost-effective strategy is to
sequence those subjects with the extreme trait values prefer-
entially. This strategy can substantially increase statistical power
(relative to sequencing a random sample with the same number
of subjects), as suggested by research in various contexts (1–9).
Indeed, such trait-dependent sampling has been adopted in
many sequencing projects, including the National Heart, Lung,
and Blood Institute (NHLBI) Exome Sequencing Project (ESP)
and the Cohorts for Heart and Aging Research in Genomic Ep-
idemiology (CHARGE) resequencing project. The NHLBI ESP
consists of multiple studies, each of which is focused on one trait.
For the body mass index (BMI) study, 267 subjects with BMI
values >40 and 178 subjects with BMI values <25 were selected
for sequencing out of a total of 11,468 subjects from Women’s
Health Initiative (WHI). Similar designs were used for the LDL
and blood pressure (BP) studies, although the sampling was based
on residuals (to adjust for age, sex, race, and medication) rather
than raw measurements.
Case–control testing is a valid option for comparing the two
extremes of a quantitative trait. If the underlying association is
quantitative, however, case–control analysis will not be optimal
for three major reasons. First, it is less powerful than quanti-
tative trait analysis. Second, it does not estimate the quantitative
relationship. Third, its results cannot be efficiently combined
with those of other studies with different selection criteria.
In the absence of genetic association, the genetic variant
is independent of the quantitative trait in the extremes (Fig. 1,
Upper); therefore, standard linear regression, which ignores
trait-dependent sampling, has correct type I error. In the pres-
ence of genetic association, however, standard linear regression
will yield biased estimates of genetic effects (Fig. 1, Lower).
Standard linear regression also yields biased estimates of the
effects of confounders, such as ancestry variables for capturing
population stratification (whether or not there is genetic asso-
ciation). Consequently, the type I error for testing genetic as-
sociation will be inflated when there is population stratification
(because the effects of ancestry variables are estimated with bias,
and thus not correctly adjusted for).
Most sequencing projects, especially those derived from well-
designed cohort studies, collect data on a variety of secondary
quantitative traits (i.e., quantitative traits other than the one
used to select subjects for sequencing). In the NHLBI ESP, a
large number of secondary quantitative traits are available in
each study. In particular, BMI and BP are available as secondary
traits in the LDL study. Association analysis with available data
on secondary traits is essentially a “free lunch.” By combining the
data on a particular trait that is the primary trait in one study and
a secondary trait in another, we will have a larger sample size and
higher statistical power. This is extremely important because
there is little power to detect association with rare variants in
small samples.
If the secondary trait is correlated with the primary trait, as is
often the case, the genetic effects on the secondary trait may be
distorted among the subjects with the extreme values of the
primary trait. Thus, standard linear regression may yield biased
estimates of the genetic effects on the secondary trait and cause
inflation of the type I error. The directions and magnitudes of
the bias may be different between the primary and secondary
traits. Consequently, combining the results on a particular trait
that is the primary trait in one study and a secondary trait in
another study may actually reduce instead of increase power (as
opposed to analyzing the data on the primary trait alone).
We propose valid and efficient likelihood-based methods for
analyzing both primary and secondary quantitative traits and for
combining data on a particular trait that is primary in one study
and secondary in another under trait-dependent sampling. The
newly developed approach, which is referred to as maximum
likelihood estimation (MLE), preserves the type I error while
achieving the highest power among all valid tests and yields
unbiased and efficient estimates of genetic effects. We investi-
gate the theoretical properties of the naive approach, namely,
standard linear regression, under trait-dependent sampling. We
compare the MLE and naive methods through extensive simu-
lation studies. We provide applications to the NHLBI ESP data.
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Trait-dependent sampling without covariates was previously
studied (1–8). It is important to accommodate covariates because
population stratification is expected to be a severe issue and can
be adjusted for through the use of ancestry covariates. The like-
lihood function reflecting trait-dependent sampling involves the
distribution of covariates, which is high-dimensional in the
presence of continuous covariates, and thus entails considerable
theoretical and computational challenges. We establish the de-
sired theoretical properties of the MLE through modern asymptotic
techniques and develop the corresponding score statistics, which
are computationally fast and numerically stable. We develop
three types of gene-based tests for rare variants in sequencing
studies. In addition, we theoretically investigate the efficiency
of trait-dependent sampling and quantify the bias of standard
linear regression as a function of the extremity of sampling and
as a function of the effects of confounders. No such theoretical
results were previously available (even without covariates).
The problem of analyzing secondary traits when the sampling
is based on a quantitative trait has not been studied in the lit-
erature. We develop statistically efficient and numerically stable
methods that properly account for the sampling in the analysis of
secondary quantitative traits, paying special attention to testing
rare variants in sequencing studies. We theoretically quantify the
bias of standard linear regression as a function of the correlation
between the primary and secondary traits and as a function of the
genetic effect on the primary trait. We provide a meta-analysis
method that efficiently combines the results on a quantitative
trait that is the primary trait in one study and a secondary trait in
another study. We demonstrate that our method is substantially
more powerful than the meta-analysis based on standard linear
regression.
Methods
We consider the type of design used in the NHLBI ESP, which consists of
multiple studies. In each study, a quantitative trait of primary interest (e.g.,
BMI, LDL, BP) is used to select subjects for sequencing and measurements are
available on other (i.e., secondary) quantitative traits. In the association
analysis, a particular trait of interest may correspond to the primary trait in
one study and to a secondary trait in another. In the NHLBI ESP, BMI is the
primary trait in the BMI study and a secondary trait in the LDL and BP studies,
whereas LDL is the primary trait in the LDL study and a secondary trait in the
BMI and BP studies. In this section, we first show how to analyze primary and
secondary quantitative traits in a single study and then show how to combine
results on a particular trait that is primary in one study and secondary
in another.
For a given study, let Y1 denote the primary trait and Y2 denote a sec-
ondary trait. (In general, Y1 and Y2 stand for different traits in different
studies. If sampling is based on residuals rather than raw measurements, Y1
and Y2 are defined accordingly.) Also, let G denote the genetic variable of
interest and Z denote a set of covariates. The latter may include ancestry
variables and demographic/environmental factors. For single-variant analy-
sis, G may denote the number of minor alleles the subject carries at the SNP
site or indicate whether the subject carries any minor allele at the SNP site.
For gene-based analysis, G may represent the total number of mutations
over multiple variant sites within the gene or indicate whether there is any
mutation within the gene (10–15).
Suppose that we have a cohort of n subjects, among whom n1 subjects are
selected for sequencing. We assume that the primary trait Y1 is available on
all n cohort members. (If there are missing values on Y1, we define n as the
total number of subjects with available Y1.) The selection of subjects for
sequencing may depend on the values of Y1 in the entire cohort. By defi-
nition, G is available only on the n1 sequenced subjects. If Z represents an-
cestry variables (e.g., percentage of African ancestry, principal components
for ancestry) constructed from sequencing data, Z is available only on the
n1 sequenced subjects. If Z represents demographic/environmental varia-
bles, Z is potentially available on all cohort members. The secondary trait Y2
is also potentially available on all cohort subjects. For a large cohort (or a study
involving multiple large cohorts), however, it is logistically difficult and
mathematically unnecessary to retrieve the records on covariates and sec-
ondary traits for nonsequenced subjects. Thus, we assume that Z and Y2 are
available only on the n1 sequenced subjects. The values of Z and Y2 may be
missing among the sequenced subjects. We impute the missing values of
Z by their sample means and leave the missing values of Y2 unchanged.
Based on the above considerations, Y1 is available on n subjects; ðG; ZÞ is
available on a subset of n1 subjects; and Y2 is available on a further subset
of, say, n2 subjects. We order the data so that the n2 subjects with the
available Y2 measurements appear first and the remaining ðn1 −n2Þ se-
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where P denotes the density or conditional density function.
It is natural to formulate the joint distribution of Y1 and Y2 through the
bivariate linear regression model:
Y1 = β1G+ γ
T
1Z + e1; [2]
Y2 = β2G+ γ
T
2Z + e2; [3]
where ðe1; e2Þ is bivariate normal with mean zero and covariance matrix
fσkl ; k; l= 1; 2g. We absorb the unit component in Z so that the first com-
ponents of γ1 and γ2 pertain to the intercepts. The conditional distribution
of Y2, given ðY1;G; ZÞ, satisfies the linear model
Y2 = δY1 + ~β2G+~γ
T
2Z +~e2; [4]
where δ= σ12=σ11, ~β2 = β2 − ðσ12=σ11Þβ1, ~γ2 = γ2 − ðσ12=σ11Þγ1, and ~e2 is in-
dependent of e1 with mean zero and variance ~σ22 = σ22 − σ212=σ11.
In gene-based analysis, G pertains to aggregate information about the
mutations within the gene (10–15). If G indicates, by the values 1 vs. 0,
whether or not there is any mutation within the gene, β1 and β2 have simple












































Fig. 1. Density functions of a quantitative trait in the absence (Upper) and
the presence (Lower) of genetic association. In the absence of genetic as-
sociation, there is no relationship between the trait value and the genetic
mutation in each of the two tails. When the mutation tends to increase the
trait value, most of the subjects in the right tail have the mutation, whereas
most of the subjects in the left tail do not have the mutation; therefore, the
difference in the trait distribution between the subjects with and without
the mutation is larger in the two tails than in the general population.
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interpretations. If G is the total number of mutations within the gene, there
is an implicit assumption that each mutation has the same effect on the
quantitative trait. If G is a weighted sum of the mutation counts, β1 and β2
can only be interpreted at the aggregate level and the inference is focused
on testing rather than estimation.
Note that Expression 1 is a nonparametric likelihood in that the (poten-
tially high-dimensional) distribution of ðG; ZÞ is not parametrized. In SI
Methods, section A, we describe a computationally efficient and numerically
stable expectation-maximization (EM) algorithm for maximizing Expression 1
and show that the resulting maximum likelihood estimators of β1 and β2
are approximately unbiased, normally distributed, and statistically effi-
cient. The corresponding test statistics have correct type I error (at least
when the sample size is large enough) and are more powerful than any
other valid tests.
To make an inference about β1, the naive method is to perform standard
least-squares estimation under model Eq. 2. This method has correct type I
error if and only if there are no confounders. In the presence of genetic
association, this method yields biased estimates of genetic effects, whether
or not there are confounders, and the degree of bias depends on the ex-
tremity of sampling (SI Methods, section B).
To make an inference about β2, the naive approach is to perform standard
least-squares estimation under model Eq. 3 or model Eq. 4. We refer to these
two methods as naive-M and naive-C, respectively, where M and C stand for
marginal and conditional, respectively. The naive-C method accounts for
trait-dependent sampling because Y1 is included as a covariate; however, ~β2
is not equal to β2 unless β1 = 0 or σ12 = 0. Thus, the naive-C method has in-
flated type I error and biased estimation if the primary and secondary traits
are correlated and there is a genetic effect on the primary trait. This con-
clusion also holds for the naive-M method. In addition, the naive-M method
has inflated type I error in the presence of confounders even if there is no
genetic effect on the primary trait (SI Methods, section B).
We may test the null hypotheses that β1 = 0 and β2 = 0 by using the score,
Wald, or likelihood ratio statistics. All the results reported in this paper are
based on score statistics, which are statistically more accurate and numeri-
cally more stable than Wald and likelihood statistics (13).
When the trait of interest in the association analysis is the primary trait in
one study and a secondary trait in another, we perform appropriate analysis
on that trait in each study and combine the results throughmeta-analysis. For
example, suppose that we are interested in genetic association with LDL
in the NHLBI ESP. In that case, we analyze LDL as the primary trait (i.e., Y1)
in the LDL study by calculating the score statistic for testing Hð1Þ0 : β1 =0
and analyze it as a secondary trait (i.e., Y2) in the BMI and BP studies by
calculating the score statistics for testing Hð2Þ0 : β2 = 0. (We may perform
association analysis on BMI or BP in a similar manner by redefining Y1
and Y2 in each study.) We then take the sum of the score statistics on the
trait of interest over all the studies to produce an overall test statistic.
Likewise, we obtain an overall estimate of the genetic effect on the trait
of interest by applying the familiar inverse-variance weighting method
to the parameter estimates and variance estimates for that trait from all
the studies. This type of meta-analysis is equivalent to the joint analysis
of the raw data of all the studies (16). The meta-analysis methods that
combine the naive method for the primary trait with the naive-M and
naive-C methods for the secondary trait are referred to as the naive-M′ and
naive-C′ methods, respectively.
The power of the naive and MLE methods is theoretically investigated in
SI Methods, section C. For detecting the genetic effect on the primary trait
in the absence of a confounder, the naive and MLE methods have similar
power. For detecting the genetic effect on the secondary trait when there is
neither a confounder nor a genetic effect on the primary trait, the MLE and
naive-C methods have similar power and are more powerful than the naive-
M method. For combining results on a particular trait that is primary in one
study and secondary in another, the MLE method tends to be much more
powerful than the naive-M′ and naive-C′ methods. Indeed, the naive-M′ and
naive-C′ methods can be less powerful than the analysis of one study only.
The loss of power by the naive-M′ and naive-C′ methods is due to the fact
that the naive estimates of the genetic effects have different magni-
tudes (or directions) of bias between the two studies (although the true
genetic effects are the same between the two studies).
In gene-based analysis, the variants whose minor allele frequencies (MAFs)
exceed a certain threshold may be excluded from the calculation of G. One
can choose a fixed threshold, such as 1% or 5%, with the corresponding tests
being called T1 and T5. Under the variable-threshold (VT) approach, one
calculates the test statistics at all possible thresholds and chooses the
threshold that minimizes the P value (12, 13). For the latter approach, it is
necessary to account for the multiple testing within the gene. This can be
accomplished by using the joint distribution of the test statistics, as described
in the last section of SI Methods, section A. To detect variants with opposite
effects on the trait, we extend the sequence kernel association test (SKAT) (14)
to reflect trait-dependent sampling (last section of SI Methods, section A).
Results
Simulation Studies. We conducted extensive simulation studies to
evaluate the performance of the MLE and naive methods in
realistic situations mimicking the NHLBI ESP. We generated
two quantitative traits from Eqs. 2 and 3 in which G is the total
number of mutations in a gene consisting of 11 variants with
MAFs pj = 0:001j ðj= 1; . . . ; 10Þ and p11 = 0:04 (13), Z is a nor-
mally distributed confounder (representing a principal com-
ponent for ancestry or a different genetically related variable)
with mean g conditional on G= g and unit variance, and e1 and
e2 are potentially correlated standard normal variables. (The
variables G and Z have a Pearson correlation coefficient of
∼0.38 or R2 of ∼0.14.) We generated a cohort of 10,000 subjects
and retained the values of ðG;Z;Y2Þ for the 250 subjects with the
smallest values of Y1 and the 250 subjects with the largest values
of Y1. We assessed the bias and type I error for the MLE and
naive methods. For making inference on β1, we varied the value
of γ1; for making inference on β2, we set γ1 = γ2 = 0 and varied
the values of β1 and σ12. The parameter values were chosen to
reflect the ESP data. We set the nominal significance level α at
10−3 and used 1 million replicates.
The results for type I error rates are shown in Fig. 2 (Left).
MLE has correct control of the type I error. For testing the
genetic effect on the primary trait, the naive method has correct
type I error in the absence of confounding but has inflated type I
error when the effect of the confounder is strong. For testing the
genetic effect on the secondary trait, the two naive methods have
inflated type I error if the primary and secondary traits are
correlated and there is a genetic effect on the primary trait; the
inflation is much more severe for the naive-M method than for
the naive-C method.
The results for bias are shown in Fig. 2 (Right). MLE is un-
biased for estimating the genetic effects on both the primary and
secondary traits. For estimating the genetic effect on the primary
trait, the naive method can be severely biased whether or not the
potential confounder has any effect on the trait. The bias is a
nonlinear function of the effect of the confounder, which is
consistent with the theory of SI Methods, section B. For esti-
mating the genetic effect on the secondary trait, the two naive
methods are biased when the primary and secondary traits are
correlated and there is a genetic effect on the primary trait.
To investigate power, we generated two studies with the above
design. The trait of interest was the primary trait in study I and
the secondary trait in study II. This setup mimicked the situation
where we are interested in BMI, which is the primary trait in the
BMI study and a secondary trait in the LDL study. To make
fair power comparisons, we considered the setting in which all
competing methods have correct type I error. Specifically, we
assumed that there is no confounding and that there is no genetic
effect on the primary trait in study II, such that the naive
methods for testing genetic association with the trait of interest
have correct type I error in both study I and study II, and thus
also have correct type I error in the meta-analysis. (The MLE
methods always have correct type I error.)
Fig. 3 displays the power curves of the MLE and naive
methods for detecting the genetic effect on the trait of interest.
When the genetic effect is zero, the power (i.e., type I error) of
all the methods is indeed near the nominal significance level.
When the genetic effect is nonzero, MLE is slightly more pow-
erful than the naive method in study I. In study II, MLE and
the naive-C method have similar power, whereas the naive-M
method has lower power. In the meta-analysis, MLE is sub-
stantially more powerful than both the naive-M′ and naive-C′
methods. Indeed, the two naive meta-analysis methods are less
powerful than the naive method for analyzing the primary trait in
study I. The loss of power is due to different degrees of bias: The
naive estimate for the primary trait in study I is severely biased
upward, whereas the two naive estimates, naive-M and naive-C,












for the secondary trait in study II are unbiased (in our simulation
setup). For Fig. 3 (Right), the bias of the naive estimate for the
primary trait in study I is about 0.83, which is more than fourfold
the effect size, whereas the naive estimates for the secondary
trait in study II are virtually unbiased. As shown in SI Methods,
section C, meta-analysis of estimates with different degrees of
bias can reduce power.
We also evaluated the MLE and naive versions of the VT test
in simulation studies. We simulated data in the same manner as
before but performed the association test by maximizing the
absolute value of the test statistic over the observed MAF thresh-
olds (and accounting for the multiple testing). The MLE ap-
proach continues to outperform the naive methods (Fig. S1).
The CHARGE resequencing project adopted a one-tailed
sampling design by selecting subjects with the highest values of a
quantitative trait, along with a random sample. Our general frame-
work covers this scenario. We conducted a series of simulation
studies mimicking the CHARGE design. Specifically, we generated
a cohort of 12,000 subjects in the same manner as in the previous
simulation studies but selected the 200 subjects with the highest
values of Y1 and a random sample of 1,000 subjects (rather than
250 subjects with the highest values of Y1 and 250 subjects with
the lowest values of Y1). This sampling is much less extreme
than the two-tailed sampling used in the previous simulation
studies because only the right tail is preferentially sampled and
the sample from the right tail is much smaller than the random
sample. The results analogous to Figs. 2 and 3 are displayed in
Figs. S2 and S3. The MLE methods continue to perform well.
Because the sampling is much less extreme than before (i.e., the
two-tailed sampling), the naive methods perform differently: (i)
the naive methods are less biased than before, especially for the
primary trait; (ii) the naive-Cmethod ismore biased than the naive-
M method; and (iii) the loss of power for the naive meta-analysis
(relative to the MLE meta-analysis) is less severe than before.
To assess the robustness of the methods to the normality as-
sumption, we simulated data in the same manner as in the first
series of simulation studies but set e1 and e2 to F−1ðΦðep1ÞÞ and
F−1ðΦðep2ÞÞ, respectively, where ðep1; ep2Þ is bivariate normal with
means 0, variances 1, and correlation 0.2; F is the distribution
function of a t random variable; and Φ is the distribution function
of a standard normal random variable. The results are shown
in Figs. S4 and S5. Both the MLE and naive tests have inflated
type I error when the degree of freedom is low and have ap-
propriate type I error when the degree of freedom is high. Even
under random sampling, the least-squares methods have inflated
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Fig. 2. Type I error (divided by the nominal significance level α) in testing no
genetic association and bias in estimating the genetic effect for the MLE and
naive methods. (Top) Results for the primary trait as a function of the effect of
a confounder. (Middle) Results for the secondary trait as a function of the genetic
effect on the primary trait when the correlation between the primary and sec-
ondary traits is 0.2. (Bottom) Results for the secondary trait as a function of the
correlation between the primary and secondary traits when the genetic effect on
the primary trait is 0.2. (Right) For the bias estimates, the true effects are 0.2.











































































Power for Study I
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Fig. 3. Power of theMLE and naivemethods in detecting genetic association
in study I, study II, and the meta-analysis. (Left) Power as a function of the
genetic effect on the trait of interestwhen the correlationbetween the primary
and secondary traits in study II is 0.2. (Right) Power as a function of the
correlation between the primary and secondary traits in study II when the
genetic effect on the trait of interest is 0.2, corresponding to R2 of 6%.
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type I error when the degree of freedom is low. In this sense, the
MLE tests under trait-dependent sampling are as robust to the
normality assumption as the least-squares methods under random
sampling. In the presence of genetic effects, the MLEmethods yield
noticeable bias, especially for the primary trait, but the bias is
considerably smaller than that of the naive methods and de-
creases as the degree of freedom increases.
NHLBI ESP. The NHLBI ESP is a signature project of the National
Institutes of Health (NIH) Recovery Act investment. It was
designed to identify genetic variants in all protein-coding regions
of the human genome that are associated with heart, lung, and
blood diseases. The project consists of multiple studies, each
of which is focused on one trait. There are three studies that
sequenced the subjects with extreme values of a quantitative
trait (i.e., BMI, LDL, BP), one case–control study on myocardial
infarction (MI), and one case-only study on stroke. As men-
tioned in the Introduction, 267 subjects with BMI values >40 and
178 subjects with BMI values <25 were selected for sequencing
out of a total of 11,468 subjects from the WHI. For the LDL
study, 120 subjects with the highest LDL values and 120 subjects
with the lowest LDL values were selected out of ∼22,000
European Americans from four cohorts: the Atherosclerosis
Risk in Communities (ARIC) study, Cardiovascular Health Study
(CHS), Framingham Heart Study (FHS), and Jackson Heart
Study (JHS); likewise, 120 subjects with the highest LDL values
and 120 subjects with the lowest LDL values were selected out
of ∼7,000 African Americans from the same cohorts. The LDL
values were adjusted for age, sex, and lipid medication, and the
adjusted LDL values for the selected subjects were lower than the
first percentile and greater than the 99th percentile for European
ancestry and lower than the third percentile and greater than the
97th percentile for African ancestry. For the BP study, 850 sub-
jects were selected from the upper and lower 0.2–1.0% of the BP
distribution (adjusted for sex, age, race, BMI, and antihyper-
tensive treatment) out of ∼100,000 European Americans and
∼20,000 African Americans from seven cohorts: the ARIC study,
Cardiovascular Risk in Communities Study (CARDIA), CHS,
FHS, JHS, Multiethnic Study of Atherosclerosis (MESA), and
WHI. The MI study consists of 650 cases with early MI and 650
controls free of MI drawn from the ARIC study, CHS, FHS, JHS,
and WHI. The stroke study consists of 600 subjects with ischemic
stroke from the ARIC study, CHS, FHS, MESA, and WHI. In
addition to the above five studies, there is a random sample of
1,000 European Americans and 500 African Americans from the
CARDIA, CHS, FHS, JHS, MESA, and WHI who have a pre-
defined common set of core variables (i.e., phenotypes, traits),
which is referred to as a deeply phenotyped reference (DPR).
Although each cohort was involved in multiple studies, no subject
was selected into more than one study. The ages of the subjects
range between 50 and 79 y, 20 and 88 y, 12 and 69 y (<20 y for 4
subjects), 20 and 92 y, 19 and 84 y, and 24 and 87 y in the BMI,
LDL, BP, MI, stroke, and DPR studies, respectively. The traits
were measured in the same way in all studies. Exome sequencing
was performed at the University of Washington and the Broad
Institute using the Roche NimbleGen SeqCap EZ or Agilent
SureSelect Human All Exon 50 Mb (17).
For illustration, we considered LDL as the trait of interest,
which is the primary trait in the LDL study and a secondary trait
in the BMI, BP, MI, and stroke studies. We used both the MLE
and naive methods to analyze the LDL trait in the LDL, BMI,
and BP studies and performed standard linear regression anal-
ysis of LDL in the MI study (adjusted for the MI status), stroke
study, and DPR. [Both early MI and ischemic stroke are rel-
atively rare. For a case–control or case-only study with rare
disease, standard linear regression analysis of secondary quan-
titative traits conditional on the disease status yields approxi-
mately correct results (18).] After restriction to subjects with
available sequencing data and exclusion of subjects with sex
mismatch or relatedness, there are 412, 489, 656, 839, 428, and
699 subjects in the LDL, BMI, BP, MI, stroke, and DPR studies,
respectively. The corresponding numbers of subjects with non-
missing LDL values are 412, 72, 351, 617, 61, and 457. Variants
for all studies were called jointly at the University of Michigan.
To ensure high-quality genotype calls for the analysis, the indi-
vidual genotype values were set to missing if the genotype depth
was lower than 10. To reduce the number of variant calls due to
sequencing and alignment artifacts, a support vector machine
was used to separate likely true-positive results from likely arti-
facts by using a variety of SNP quality metrics, including allelic
balance (the proportional representation of each allele in likely
heterozygotes), base quality distribution for sites supporting the
reference and alternate alleles, and distribution of supporting
evidence between strands and sequencing cycle. After imple-
mentation of these quality-control filters, there are a total of
115,515 SNPs with call rates >90% and MAFs ≥0.5%. Approx-
imately 60% of the SNPs are in exons. We focused on single-
variant analysis under the additive mode of inheritance and in-
cluded the top five principal components for ancestry, cohorts,
and sequencing centers/targets as covariates. The natural loga-
rithm was applied to the LDL and BMI values.
Fig. S6 displays the quantile–quantile plots for the MLE
analysis of the LDL study and for the meta-analysis of the six
studies based on the MLE, naive-M′, and naive-C′ methods. For
the MLE analysis of the LDL study and the MLE meta-analysis,
the observed P values agree very well with the global null hy-
pothesis of no association, except at the extreme right tails. By
contrast, the observed P values of the naive-M′ and naive-C′
methods deviate substantially from the null distribution,
reflecting excessive false-positive results. The inflation is likely
due to two sources: (i) some SNPs exhibit strong population
stratification, and (ii) some SNPs are associated with BMI or BP,
Table 1. MLE and naive P-values in the analysis of the LDL study, in the meta-analysis of the other (i.e., BMI, BP, MI,
Stroke and DPR) studies, and in the meta-analysis of all six studies for the top 10 SNPs from the LDL study
Naive




LDL others all others all others all
1 0.053 4.11e-07 1.92e-08 7.18e-13 2.27e-07 2.93e-08 7.77e-11 1.87e-08 4.72e-11
2 0.162 3.06e-06 3.60e-02 5.00e-07 3.13e-06 3.68e-02 4.35e-03 3.74e-02 4.48e-03
3 0.123 9.71e-06 3.36e-01 6.19e-05 1.01e-05 2.78e-01 8.77e-02 3.46e-01 1.17e-01
4 0.123 1.92e-05 3.36e-01 9.86e-05 1.85e-05 2.78e-01 9.11e-02 3.46e-01 1.22e-01
5 0.178 2.93e-05 3.26e-01 1.24e-04 2.32e-05 3.05e-01 1.04e-01 3.26e-01 1.14e-01
6 0.122 3.28e-05 4.23e-01 2.28e-04 3.64e-05 3.74e-01 1.42e-01 4.35e-01 1.74e-01
7 0.132 3.46e-05 8.55e-01 8.72e-04 5.65e-05 7.94e-01 3.93e-01 8.73e-01 4.51e-01
8 0.197 3.51e-05 6.62e-01 2.25e-03 7.38e-05 6.81e-01 8.17e-01 6.64e-01 8.37e-01
9 0.080 3.69e-05 5.73e-01 1.69e-03 3.00e-05 5.39e-01 8.81e-01 5.82e-01 8.34e-01
10 0.210 3.97e-05 7.43e-01 8.79e-04 3.79e-05 7.35e-01 3.64e-01 7.46e-01 3.72e-01












both of which are correlated with LDL. There is good concor-
dance between the MLE analysis of the LDL study and the MLE
meta-analysis: The top two SNPs are the same between the two
analyses, although the meta-analysis yields more extreme P val-
ues, especially for the top SNP, and the third, fourth, and fifth
SNPs in the LDL study are the 11th, 15th, and 22th SNPs in
the meta-analysis. The results from the naive-M′ and naive-C′
methods are very similar to each other but are quite different
from those of the MLE meta-analysis: The lists of the top 20
SNPs based on the naive-M′ and naive-C′ methods have 18
overlaps but only have 5 overlaps with the MLE list.
Table 1 shows the MLE and naive P values in the analysis of the
LDL study, in the meta-analysis of the other studies (i.e., BMI, BP,
MI, stroke, DPR), and in the meta-analysis of all six studies for the
top 10 SNPs from the MLE analysis of the LDL study. For those 10
SNPs, theMLE P values in themeta-analysis of the other studies are
similar to their naive counterparts. However, the P values for the
MLE meta-analysis of the six studies are much more significant
than those of the naive-M′ and naive-C′ methods. Indeed, all the
MLE P values are less than 0.01, whereas only the top 2 SNPs using
the naive-M′ and naive-C′ methods have P values <0.01.
The forest plots shown in Fig. S7 help to explain the results of
Table 1. TheMLEestimate for the LDL study is similar to those of
the BP, MI, and DPR studies. (There are very few subjects with
available LDL measurements in the BMI and stroke studies; thus,
the estimates in those two studies are associated with very high
variabilities.) Thus, the estimate of the MLE meta-analysis is
similar to the MLE estimate of the LDL study but with a smaller
SE. The naive estimate for the LDL study is sevenfold larger than
the MLE estimate, with a SE that is also sevenfold larger. Due
to the extreme trait-dependent sampling, the naive estimate is
expected to have this magnitude of bias. Because the naive esti-
mate in the LDL study is severely biased, whereas the estimates in
the other studies are roughly unbiased, the naive-M′ and naive-C′
methods yield less significant results than the analysis of the LDL
study alone. This phenomenon is consistent with the theoretical
analysis (SI Methods, section C) and simulation results (Fig. 3).
We also performed gene-based association tests on rare var-
iants. We considered polymorphic variants that are nonsynon-
ymous, stop-gain, stop-loss, or splicing mutations according to
the ANNOVAR (functional annotation of genetic variants from
high-throughput sequencing data) annotation. We excluded any
gene whose total number of mutations is fewer than four and
ended up with a total of 16,167 genes. There were a total of
632,003 variants in these genes. For each gene, we defined G
as the total number of mutations and applied both the MLE
and naive versions of the T1, T5, Madsen–Browning (MB) (11),
and VT tests, and the SKAT. For the MB test, each mutation is
weighted by the inverse SD of its frequency. The results are
displayed in Figs. S8–S12. The conclusions regarding the
performance of the MLE and naive tests are similar to those of
the single-variant analysis.
Discussion
Trait-dependent sampling provides a cost-effective strategy to
conduct sequencing studies of quantitative traits. Failure to ac-
count for the biased nature of the sampling can yield gross in-
flation of type I error and severe loss of power, especially in meta-
analysis. Indeed, meta-analysis of standard linear regression
results can be less powerful than the analysis of a single study, as
shown in our theoretical analysis, simulation studies, and real
data. The MLE methods presented in this paper maximize sta-
tistical power while preserving type I error. The corresponding
numerical algorithms are stable and fast. It took ∼10 s on an IBM
HS21 machine to perform one association test for an ESP study.
Case–control sampling is also a form of trait-dependent sam-
pling in that the sampling is based on the disease status. The type
of trait-dependent sampling studied in this paper differs from
case–control sampling in that the trait is continuous rather than
binary. It is well known that case–control sampling can be ig-
nored in the logistic regression analysis of case–control data (19).
By contrast, trait-dependent sampling on a quantitative trait
cannot be ignored in the linear regression analysis, as demon-
strated in this paper, although odds ratio parameters are un-
affected (9). There exist MLE methods for analyzing secondary
traits in case–control studies (18, 20). If the selection probabil-
ities of cases and controls are known, simple weighting methods
(21) can also be used, although they are not as efficient as MLE
methods. Weighting methods cannot be applied to the ESP LDL,
BMI, or BP study because the subjects with nonextreme trait
values had zero probabilities of being selected.
We have focused on secondary quantitative traits. In the
NHLBI ESP, investigators are interested in secondary binary
traits (e.g., type I diabetes) and longitudinal traits (e.g., diastolic
and systolic blood pressures). We are currently extending the MLE
methods to such traits.
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